DrugRisk continues to track news about the popular atrial fibrillation blood thinner drug Pradaxa. And lately, that news isn’t positive.
Last fall, a federal judge handling thousands of internal bleeding injury claims fined drug maker Boehringer Ingelheim nearly $1 million for concealing evidence. In January, the FDA announced it would launch a new Pradaxa safety study, and reports suggest the company didn’t share data showing higher-than-expected bleeding rates.
Now, Boehringer has admitted on its own website, Pradaxa.de, that they’ve received at least 10,798 reports of major internal bleeding among Pradaxa users through December, 2013. Even worse, 1,646 of these were fatal.
Patient advocate groups have called for new label warnings on Pradaxa, or even a recall. However, Boehringer Ingelheim continues to claim the drug is safe.
In the meantime, more than 2,000 families have filed a Pradaxa lawsuit over serious or fatal internal bleeding. The growing litigation has been consolidated to a special federal court.
The judge handling the Pradaxa lawsuits recently scheduled trials to start in August.
If you or a loved one suffered internal bleeding while taking Pradaxa, it is important to speak with a lawyer. It costs nothing to discuss your case or file a lawsuit unless you recover.
Due to the complex nature of these cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits. Contact us today for more information or to speak with a lawyer.